Our team is heading to ACTRIMS 2/29-3/2 and we look forward to connecting with you! More

Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Browse our latest publications below.

Serum Biomarkers of Clinical and Radiographic Disease Progression in Multiple Sclerosis

Interpretable Thalamic Volume Charts in Multiple Sclerosis

Disagreement Among Neuroradiologists Detecting Change in Multiple Sclerosis Disease Activity

Disease Activity Score and Disease Pathway Scores Measured Using the Multiple Sclerosis Disease Activity Test are Significantly Reduced Prior to the Week 96 Dose for Patients Treated with Ublituximab in the Phase 3 ULTIMATE I and II Studies

Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis

Longitudinal Robustness of Emergent MS Phenotypes from Multiprotein Serum

Robustness of Emergent Clusters from Multi-Protein Serum Data

Variability in Clinical Decision Making for Neurologists Interpreting MS MRI Brain Reports

The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence

Detection of Silent UTI – a Case Study

1 2 3 8

Serum Biomarkers of Clinical and Radiographic Disease Progression in Multiple Sclerosis

Interpretable Thalamic Volume Charts in Multiple Sclerosis

Disagreement Among Neuroradiologists Detecting Change in Multiple Sclerosis Disease Activity

Disease Activity Score and Disease Pathway Scores Measured Using the Multiple Sclerosis Disease Activity Test are Significantly Reduced Prior to the Week 96 Dose for Patients Treated with Ublituximab in the Phase 3 ULTIMATE I and II Studies

Clinical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis

Longitudinal Robustness of Emergent MS Phenotypes from Multiprotein Serum

Robustness of Emergent Clusters from Multi-Protein Serum Data

Variability in Clinical Decision Making for Neurologists Interpreting MS MRI Brain Reports

The Impact of Octave’s Clinical Insights (a patient support program) on Medication Adherence

Detection of Silent UTI – a Case Study